Navigation Links
Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
Date:3/17/2009

Alexandria, Va. The International Association for Dental Research (IADR) has selected Dr. Athena Papas, from Tufts University, Boston, Massachusetts, USA, as the 2009 recipient of the Pharmacology/Therapeutics/Toxicology Research Award. The award will be presented at the IADR 87th General Session & Exhibition in Miami, Florida, USA, on April 1, 2009 Dr. Papas is the Erling Johansen Professor of Research, as well as a professor in the Department of General Dentistry at the Tufts University School of Dental Medicine. She received her Ph.D. from the Massachusetts Institute of Technology in 1971, followed by her dental degree from Harvard University School of Dental Medicine in 1974.

Dr. Papas has had a very active and distinguished research career in multiple areas of dental drug and device therapy. Her major focus has been as principal investigator in clinical trials involving various aspects of dry mouth (xerostomia), including drug therapy for patients with Sjgren's syndrome, devices to stimulate salivary flow, and understanding why patients with dry mouth are susceptible to tooth decay. She has spearheaded numerous other areas of therapeutic research that have included studies on tooth sensitivity, effects of implants in restoring nutrition in the elderly, and means of improving the oral health of head and neck cancer patients who receive radiation therapy.

The total amount of grant money that Dr. Papas has secured during her nearly 30-year academic career exceeds $20 million. She has published articles, presented her research findings at numerous AADR and IADR meetings, and been a peer reviewer for many scholarly journals, including the IADR's Journal of Dental Research, Gerontology, and the New England Journal of Medicine.

Supported by Wyeth Consumer Healthcare, the Pharmacology/Therapeutics/Toxicology Research Award is one of the 16 IADR Distinguished Scientist Awards and is one of the highest honors bestowed by IADR. The Award is made for outstanding and sustained peer-reviewed research that has contributed to our knowledge of the mechanisms, efficacy, or safety of drugs used in dentistry and consists of a monetary prize and a plaque.


'/>"/>

Contact: Ingrid Thomas
ithomas@iadr.org
703-299-8084
International & American Association for Dental Research
Source:Eurekalert

Related biology news :

1. Tufts University Prof. Maria Flytzani-Stephanopoulos named as AAAS Fellow
2. Tufts to develop morphing chemical robots
3. Tufts University biologists link Huntingtons disease to health benefits in young
4. IADR Wilmer Souder Award presented to University of Colorado professor
5. Troutlodge, University of Miami sign aquaculture agreement
6. Ben-Gurion University engineers develop technique to help combat nuclear proliferation
7. Undesirable evolution can be reversed in fish, Stony Brook University scientists show
8. Ben-Gurion University of the Negev researchers develop new reversible, green window technology
9. Queens University Belfast improves Malaysian public health
10. If youre aggressive, your dog will be too, says veterinary study at University of Pennsylvania
11. Famous fossil Lucy scanned at the University of Texas at Austin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... , ... March 22, 2017 , ... ... human tissue regeneration from small lab samples to full-size tissues, bones, even whole ... establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... , March 22, 2017  UBM and the ... announce their extended partnership and the third annual Massachusetts ... by the 21 st Annual MassMEDIC Conference ... place May 3-4, 2017. MassMEDIC ... Association (ADVAMED) President and CEO, Scott Whitaker ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
Breaking Biology Technology: